IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Other Long-Term Liabilities: ₹958 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:IOLCP IOL Chemicals And Pharmaceuticals Ltd NSE:IOLCP
64 GF Score
Price ₹151.00
GF Value ₹94.57
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is IOL Chemicals And Pharmaceuticals Other Long-Term Liabilities?

IOL Chemicals And Pharmaceuticals NSE:IOLCP -2.85% 64 Other Long-Term Liabilities is ₹958 Mil as of Mar. 2026. GuruFocus rates NSE:IOLCP with a GF Score™ of 64/100 and a GF Value™ of ₹94.57 (Significantly Overvalued). The stock has 2 warning signs investors should review.

IOL Chemicals And Pharmaceuticals's other long-term liabilities for the quarter that ended in Mar. 2026 was ₹958 Mil.

IOL Chemicals And Pharmaceuticals's quarterly other long-term liabilities declined from Sep. 2025 (₹878 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹958 Mil).

IOL Chemicals And Pharmaceuticals's annual other long-term liabilities increased from Mar. 2024 (₹662 Mil) to Mar. 2025 (₹778 Mil) and increased from Mar. 2025 (₹778 Mil) to Mar. 2026 (₹958 Mil).

IOL Chemicals And Pharmaceuticals Other Long-Term Liabilities Related Terms

IOL Chemicals And Pharmaceuticals Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for IOL Chemicals And Pharmaceuticals's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IOL Chemicals And Pharmaceuticals Other Long-Term Liabilities Chart

IOL Chemicals And Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 562.40 565.00 661.80 778.10 958.20

IOL Chemicals And Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 778.10 0.00 878.30 0.00 958.20
NSE:IOLCP
64GF Score
IOL Chemicals And Pharmaceuticals Ltd NSE:IOLCP
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IOL Chemicals And Pharmaceuticals Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of ₹958 Mil mean?
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) has a Other Long-Term Liabilities of ₹958 Mil as of Mar. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on IOL Chemicals And Pharmaceuticals and its competitors.
Is IOL Chemicals And Pharmaceuticals' Other Long-Term Liabilities too high?
IOL Chemicals And Pharmaceuticals' current Other Long-Term Liabilities is ₹958 Mil. Overall, IOL Chemicals And Pharmaceuticals has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IOL Chemicals And Pharmaceuticals' Other Long-Term Liabilities compare to ZTS and UTHR?
IOL Chemicals And Pharmaceuticals' Other Long-Term Liabilities of ₹958 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Drug Manufacturers company?
A good Other Long-Term Liabilities depends on the Drug Manufacturers industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. IOL Chemicals And Pharmaceuticals's current Other Long-Term Liabilities is ₹958 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IOL Chemicals And Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals (NSE:IOLCP) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹94.57, compared to a current price of ₹151.00 — trading 59.7% above its estimated fair value. The current Other Long-Term Liabilities is ₹958 Mil. IOL Chemicals And Pharmaceuticals' overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For IOL Chemicals And Pharmaceuticals (NSE:IOLCP), the current Other Long-Term Liabilities is ₹958 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Overvalued in 2026?

Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals stock appears to be overvalued. The current stock price of ₹151.00 is trading 59.7% above its estimated GF Value™ of ₹94.57. GuruFocus considers IOL Chemicals And Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for NSE:IOLCP:

  • Other Long-Term Liabilities: ₹958 Mil
  • GF Value™: ₹94.57 vs. price of ₹151.00 (59.7% above fair value)
  • GF Score™: 64/100 with 2 warning signs

No single metric tells the full story. See the NSE:IOLCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IOL Chemicals And Pharmaceuticals Business Description

Other Exchanges 524164:India
Address 85, Industrial Area, A, Ludhiana, PB, IND, 141 003
IOL Chemicals And Pharmaceuticals Ltd is an India-based pharmaceutical company. The primary activity of the group is the manufacturing and sale of drugs and organic chemicals. The business activity is functioned through the Chemicals and Pharmaceutical segments. The Chemicals segment produces and sells chemicals such as Ethyl Acetate, Acetic Anhydride, Acetyl Chloride, Mono Chloro Acetic Acid, and Iso Butyl benzene, whereas the Pharmaceutical segment produces and sells various active pharmaceutical ingredients such as Ibuprofen, Metformin, Fenofibrate, Lamotrigine, and others. It derives prime revenue from the Pharmaceutical segment. Geographically, the group's products are sold in both the Indian and international markets.
64GF Score

Get the complete analysis for NSE:IOLCP

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹151.00
Price
₹94.57
GF Value